GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytori Cell Research Institute Inc (TSE:3750) » Definitions » Other Operating Expense

Cytori Cell Research Institute (TSE:3750) Other Operating Expense : 円2,284 Mil (TTM As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Cytori Cell Research Institute Other Operating Expense?

Cytori Cell Research Institute's Other Operating Expense for the three months ended in Dec. 2023 was 円568 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was 円2,284 Mil.

Cytori Cell Research Institute's quarterly Other Operating Expense increased from Jun. 2023 (円538 Mil) to Sep. 2023 (円544 Mil) and increased from Sep. 2023 (円544 Mil) to Dec. 2023 (円568 Mil).

Cytori Cell Research Institute's annual Other Operating Expense declined from Mar. 2021 (円1,492 Mil) to Mar. 2022 (円1,322 Mil) but then increased from Mar. 2022 (円1,322 Mil) to Mar. 2023 (円2,063 Mil).


Cytori Cell Research Institute Other Operating Expense Historical Data

The historical data trend for Cytori Cell Research Institute's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytori Cell Research Institute Other Operating Expense Chart

Cytori Cell Research Institute Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 154.59 730.24 1,491.99 1,321.56 2,063.35

Cytori Cell Research Institute Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 510.69 633.60 538.22 543.96 568.42

Cytori Cell Research Institute Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円2,284 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cytori Cell Research Institute Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Cytori Cell Research Institute's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Cytori Cell Research Institute (TSE:3750) Business Description

Traded in Other Exchanges
N/A
Address
1-1-1 Otemachi, Otemachi Park Building, Chiyoda-ku, Tokyo, JPN, 100-0004
Cytori Cell Research Institute Inc developing a new clinical approach to cell therapy to provide better medical care to patients by providing medical care that responds to unmet medical needs based on innovative regenerative medicine. Its product pipeline includes Habeo; ECCO-50 and others.

Cytori Cell Research Institute (TSE:3750) Headlines

No Headlines